Back to Search Start Over

Corrections.

Source :
New York Times. 8/31/2011, Vol. 160 Issue 55514, p2. 0p.
Publication Year :
2011

Abstract

An article on Monday about Eliquis, a new stroke-preventive drug from Pfizer and Bristol-Myers Squibb, misspelled the brand name of the drug most commonly used now for that purpose. It is Coumadin, not Coumidin. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
*STROKE treatment

Details

Language :
English
ISSN :
03624331
Volume :
160
Issue :
55514
Database :
Academic Search Index
Journal :
New York Times
Publication Type :
News
Accession number :
76278486

Tools

Authors Abstract Subjects Details